ImmunoVaccine Technologies Appoints New CFO

30-Sep-2009 - Canada

Immunovaccine Technologies (IVT) announced that it has appointed Gary Dodge, CA, as Chief Financial Officer.

Reporting to president and CEO Dr. Randal Chase, Mr. Dodge will oversee IVT's accounting and financing activities. Mr. Dodge also becomes a part of the company's executive management team, which directs all aspects of company strategy, planning, and operations.

Prior to joining IVT, Mr. Dodge was SolutionInc Technologies Ltd's CFO and was responsible for financial reporting, capital financing, and financial planning. He was also a Director, Transaction Services, for PricewaterhouseCoopers LLP. While working in PwC's Calgary, Johannesburg and Boston offices, Mr. Dodge performed audit and advisory services across many industries, including mergers and acquisitions advisory services to both biotech companies and private equity clients.

Other news from the department people

More news from our other portals

So close that even
molecules turn red...